Leading Corporate Purpose Platform Continues to Invest in Growth
CALGARY, Alberta, May 7, 2020/3BL Media/ – Benevity, Inc., the leading global provider of corporate social responsibility and employee engagement software, today announced that Steven Woods will be joining the executive team as Chief Technology Officer, effective June 1, 2020. Steven will be based in Toronto leading a technology team of more than 200 development, product management, analytics and enterprise platform professionals that spans Benevity’s Calgary, Victoria and Toronto offices.
This article originally appeared in United Way’s 2019 Local Leader List in the Globe and Mail on November 9, 2019.
Most weekday mornings, Dale Storey goes to the gym at 5 a.m., has a protein shake afterwards and enjoys a bowl of cereal when he arrives at his desk. It’s a breakfast routine that’s become ingrained for the President and Managing Director of General Mills Canada Corporation.
(Toronto, Canada) <Date> — Today 25 women business owners in Canada will join a select group of graduates from the “Financing Your Growing Business” Training Boot Camp. The Training Program is implemented in partnership with WEConnect International and Moody’s Corporation through the Reshape TomorrowTM initiative.
RACINE, Wis., April 26, 2019 /3BL Media/ – SC Johnson Canada today announces it has been ranked No. 49 on the 2019 list of Best Workplaces by Great Place to Work®. This marks the 12th time the Canada operation has been recognized on the annual Best Workplace list of large and multinational workplaces in Canada, with more than 1,000 employees working in Canada or worldwide.
From successes to challenges, read the stories for these women
In light of International Women’s Day 2019, Gildan launched a campaign to recognize some of their 23,000 female employees.
Thirteen employees from seven different countries where the Company operates were invited to share their professional and personal stories. These women explored topics including passions, motivation, family, resilience and growth. Read their stories:
Introducing the Scotiabank Women Initiative, a program designed to advance women-led business in Canada through access to capital, education and mentorship. The Scotiabank Women Initiative is unique because it is a comprehensive offering of capital and resources to support women-led businesses at different stages of growth. We strongly believe that the three pillars of The Scotiabank Women Initiative – Access to Capital, Mentorship, and Education – will deliver meaningful, long-term support to women-led businesses and help women take their business to the next level.
By Sally Crane, Senior Research Associate & Executive Network Manager, Corporate Responsibility & Sustainability
Earlier in 2018, The Conference Board of Canada published the latest in their Canada 2030 series, titled The Defining Forces Disrupting Business. Written with an eye towards helping Canadian businesses and investors understand the disrupting forces likely to affect organizations over the next decade, Canada 2030: The Defining Forces Disrupting Business report encourages readers to address the risks associated with the disruptions ahead and capitalize on the opportunities they may bring.
The Conference Board of Canada, Corporate Social Responsibility Association of Turkey, and Donors Forum, Russia join CECP’s Global Exchange
CECP’s Global Exchange continues to unite country-based, mission-driven corporate engagement organizations to advance business as a force for good around the world with the addition of three new nonprofits to the group, representing Canada, Turkey, and Russia. At 16 organizations strong, the Global Exchange collectively represents 54% of the world’s population and 67% of the world’s GDP.
The word “creativity” may not be traditionally associated with scientific research, but for Elisa D’Arcangelo, it sums up some of the aspects she most values about being a biomedical engineer. As a tissue engineer, she must come up with creative solutions for growing tissue in the lab that can help shape new therapies for cancer and other diseases.